Literature DB >> 10335983

A novel C-->A transversion within the distal CCAAT motif of the Ggamma-globin gene in the Algerian Ggammabeta+-hereditary persistence of fetal hemoglobin.

S Zertal-Zidani1, T Merghoub, R Ducrocq, N Gerard, D Satta, R Krishnamoorthy.   

Abstract

Hereditary persistence of fetal hemoglobin (HPFH) is a group of genetically heterogeneous conditions characterized by the continued expression of fetal hemoglobin in adulthood. These constitute natural models for understanding the mechanism(s) of the hemoglobin switch. Many large deletions in the beta-globin gene cluster and point mutations in one of the fetal globin gene promoters have been described before. In this study we describe a novel C-->A transversion (-114) in the distal CCAAT box of the Ggamma-globin gene promoter associated with the Ggammabeta+-HPFH phenotype in an Algerian family. Individuals heterozygous for this mutation exhibit moderate raise in Hb F levels (0.6-3.5%). Much higher Hb F levels (3.8-11.2%) are observed when a beta(o)-thalassemia allele is present in trans to the hereditary persistence of fetal hemoglobin allele. This novel Algerian HPFH mutation further stresses the importance of the distal CCAAT box in the postnatal regulation of gamma-globin gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335983     DOI: 10.3109/03630269908996160

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  5 in total

Review 1.  Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.

Authors:  Vigneshwaran Venkatesan; Saranya Srinivasan; Prathibha Babu; Saravanabhavan Thangavel
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

2.  Human telomere disease due to disruption of the CCAAT box of the TERC promoter.

Authors:  Anna M Aalbers; Sachiko Kajigaya; Marry M van den Heuvel-Eibrink; Vincent H J van der Velden; Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2012-02-08       Impact factor: 22.113

3.  Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.

Authors:  Nithin Sam Ravi; Beeke Wienert; Stacia K Wyman; Henry William Bell; Anila George; Gokulnath Mahalingam; Jonathan T Vu; Kirti Prasad; Bhanu Prasad Bandlamudi; Nivedhitha Devaraju; Vignesh Rajendiran; Nazar Syedbasha; Aswin Anand Pai; Yukio Nakamura; Ryo Kurita; Muthuraman Narayanasamy; Poonkuzhali Balasubramanian; Saravanabhavan Thangavel; Srujan Marepally; Shaji R Velayudhan; Alok Srivastava; Mark A DeWitt; Merlin Crossley; Jacob E Corn; Kumarasamypet M Mohankumar
Journal:  Elife       Date:  2022-02-11       Impact factor: 8.140

4.  Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.

Authors:  Gabriella E Martyn; Beeke Wienert; Lu Yang; Manan Shah; Laura J Norton; Jon Burdach; Ryo Kurita; Yukio Nakamura; Richard C M Pearson; Alister P W Funnell; Kate G R Quinlan; Merlin Crossley
Journal:  Nat Genet       Date:  2018-04-02       Impact factor: 38.330

5.  Activation of γ-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin.

Authors:  Phillip A Doerfler; Ruopeng Feng; Yichao Li; Lance E Palmer; Shaina N Porter; Henry W Bell; Merlin Crossley; Shondra M Pruett-Miller; Yong Cheng; Mitchell J Weiss
Journal:  Nat Genet       Date:  2021-08-02       Impact factor: 38.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.